LenalidomideStevens Johnson syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1633卷 / 1期

关键词：

D O I：

10.1007/s40278-017-24710-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：442 / 442

相关论文

共 50 条

[31] CyclophosphamideStevens-Johnson syndrome and myelotoxicity: 2 case reports
Reactions Weekly, 2013, 1482 (1) : 17 - 17
[32] Fluconazole/prednisoloneStevens-Johnson syndrome: 2 case reports
Reactions Weekly, 2010, 1283 (1) : 42 - 42
[33] Meloxicam/theophyllineStevens-Johnson syndrome: 2 case reports
Reactions Weekly, 2023, 1982 (1) : 239 - 239
[34] Efavirenz/nevirapineStevens-Johnson syndrome: 2 case reports
Reactions Weekly, 2019, 1737 (1) : 122 - 122
[35] CeftriaxoneStevens Johnson Syndrome: 3 case reports
Reactions Weekly, 2023, 1957 (1) : 134 - 134
[36] EthosuximideOverlap Stevens–Johnson syndrome-toxic-epidermal-necrolysis and Stevens–Johnson syndrome: 2 case reports
Reactions Weekly, 2018, 1703 (1) : 113 - 113
[37] CapecitabineGastrointestinal toxicity and Stevens-Johnson syndrome: 2 case reports
Reactions Weekly, 2022, 1935 (1) : 126 - 126
[38] GriseofulvinStevens Johnson syndrome and toxic epidermal necrolysis: 2 case reports
Reactions Weekly, 2016, 1596 (1) : 105 - 105
[39] AntineoplasticsStevens-Johnson syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1843 (1) : 47 - 47
[40] Amoxicillin/clavulanic acidStevens-Johnson syndrome: 2 case reports
Reactions Weekly, 2017, 1671 (1) : 36 - 36

← 1 2 3 4 5 →